WebApixaban is a direct inhibitor of activated factor X (factor Xa). Indications and dose Prophylaxis of venous thromboembolism following knee replacement surgery By mouth … WebJun 8, 2024 · 4 days later, abdomen CT was obtained due to sudden severe abdominal pain, which revealed massive thrombosis of the entire portal venous system with no residual enhancement in the portal vein, splenic vein, and superior mesenteric vein (figure A, B).Extensive intraabdominal free fluid was noted with higher density in the perisplenic …

Direct oral anticoagulants in the treatment of portal vein …

WebJan 1, 2024 · To assess the outcome of direct oral anticoagulants (DOACs), specifically Xa inhibitors: rivaroxaban and apixaban, for the treatment of (VTE) of atypical location (VTE-AL), portal, mesenteric, hepatic, splenic, gonadal, renal, and cerebral veins, prospectively collected data of Mayo Thrombophilia Clinic Registry were used. Methods WebMar 2, 2016 · For VTE without an associated cancer diagnosis, all direct oral anticoagulants (dabigatran, rivaroxaban, apixaban, or edoxaban) are recommended over vitamin K antagonist (VKA) therapy (all Grade 2B) and VKA therapy is recommended over low molecular weight heparin (LMWH; Grade 2C). chinese herbal lung supplement

Rivaroxaban for the treatment of noncirrhotic splanchnic vein ...

WebJun 17, 2024 · Of the different sites of SVT, portal vein thrombosis (PVT) is the most frequently detected, with a gender-specific annual incidence of 3.78 cases per 100 000 inhabitants in men and 1.73 per 100 000 inhabitants in women. 1 Most common predisposing factors for SVT include liver cirrhosis, solid abdominal cancer, … WebApixaban, sold under the brand name Eliquis, is an anticoagulant medication used to treat and prevent blood clots and to prevent stroke in people with nonvalvular atrial fibrillation through directly inhibiting factor Xa. [5] [6] [7] Specifically, it is used to prevent blood clots following hip or knee replacement and in those with a history of ... Webdose of 200 IU/kg once daily for the first month, followed by 150 IU/kg once daily) for 6 months showed that, in this study population, apixaban was non-inferior to low molecular … chinese herbal medication liquid